New York City, NY -- (SBWIRE) -- 01/07/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
StockMarketIntel.com issues a special report on the following stocks: Pfizer Inc. (NYSE:PFE), Micron Technology, Inc. (NASDAQ:MU), Neurocrine Biosciences, Inc. (NASDAQ:NBIX), IsoRay, Inc. (NYSEMKT:ISR)
Pfizer Inc. (NYSE:PFE) gained 1.41% recently, while trading on 3.80 million shares, at the price of $30.98. The stock changed hands in a range of $30.79 to $31.02 up till now, bringing its market capitalization at about $200.78 billion. If we look at its trading history of the past 52 weeks, the share price suffered a low of $25.77 and was moved to the maximum level of $32.50. Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. The Company manages its operations through five segments: Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health, and Consumer Healthcare.
What was the Moving Force behind PFE on Bullish Run? Read This Research Report
Micron Technology, Inc. (NASDAQ:MU) added 3.39% recently, in the current trading session, at $21.37 with a total volume of 8.73 million shares. The stock, on average, trades on a volume of 38.98 million shares. It floated in a range of $20.89 to $21.72 during the recent trading session, with a beta value of 1.41. Its market capitalization now moved to about $22.60 billion. In the past 52 weeks, the share price has not declined below $7.03 or above $23.67. Micron Technology, Inc., is a global manufacturer and marketer of semiconductor devices, principally NAND Flash, DRAM and NOR Flash memory, as well as other memory technologies, packaging solutions and semiconductor systems for use in computing, consumer, networking, automotive, industrial, embedded and mobile products. In addition, the Company manufactures semiconductor components for CMOS images sensors and other semiconductor products.
For How Long MU will fight for Profitability? Read This Trend Analysis report
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) recently recorded a gain of 67.01% and was moving within a range of $15.20-$16.42, its current trading price is $16.35. The stock is moving up till now with a total volume of 5.18 million shares, versus an average volume of 563,232 shares. The share price hit its 52-week low of $8.08 and $16.74 was the best price. Neurocrine Biosciences, Inc. (Neurocrine) discovers, develops and commercializes drugs for the treatment of neurological and endocrine-related diseases and disorders. The Company’s product candidates address some of the pharmaceutical markets including endometriosis, stress-related disorders, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders.
For How Long NBIX Gloss will Attract Investors? Find out via this report
IsoRay, Inc. (NYSEMKT:ISR) added 11.47% in its current trading activity, bringing its market capitalization around $22.59 million. The share price, after opening at $0.69, hit a high of $0.69 and hovered above $0.56, while its recent trading price was $0.590. The total number of shares changed hands during the current session up till now was 1.83 million shares, as compared to average trading volume of 232,106 shares. IsoRay, Inc. (IsoRay) develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. IsoRay International LLC (International) is a wholly owned subsidiary of the Company. IsoRay obtained clearance from the Food and Drug Association for treatment for all solid tumor applications using Cesium-131.
Will ISR Continue To Move Higher? Find Out Here
To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)